Literature DB >> 4700497

The hormonal regulation of pyloric sphincter function.

R S Fisher, W Lipshutz, S Cohen.   

Abstract

The purpose of this study was to evaluate the hormonal control of pyloric sphincter function. Studies were performed on both pyloric circular muscle, in vitro, and the human pylorus, in vivo. Full dose-response curves to gastrin I, cholecystokinin, and secretin were constructed for the pyloric muscle of the opossum studied at its length of optimal tension development, Lo. Both cholecystokinin and secretin were potent agonists on the muscle but gastrin I gave no increase in muscle tension. The combination of cholecystokinin and secretin was additive at submaximal concentrations but potentiation of the maximal responses was not observed. Gastrin I produced a surmountable, competitive-like antagonism to the effect of cholecystokinin on the pyloric muscle. The octapeptide of cholecystokinin was a more potent agonist than the whole molecule of cholecystokinin on the pyloric muscle. In man, the pyloric pressure rose significantly during intravenous infusion of either cholecystokinin or secretin. The combination of maximal doses of both hormones did not show significant potentiation. Gastrin I did not significantly increase pyloric pressure but did antagonize the pyloric response to duodenal acidification. These studies suggest that: (a) Both secretin and cholecystokinin augment pyloric sphincter pressure while gastrin I is an antagonist inhibiting their effects. (b) The hormonal responses of pyloric sphincter circular muscle, in vitro, can be correlated with human sphincter function, in vivo.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4700497      PMCID: PMC302386          DOI: 10.1172/JCI107297

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Secretin and pancreozymin-cholecystokinin after glucose.

Authors:  J D Young; L Lazarus; D J Chisholm
Journal:  Lancet       Date:  1968-10-26       Impact factor: 79.321

2.  Cholecystokinin-like activities in guinea pigs and in dogs of the C-terminal octapeptide (SQ 19,844) of cholecystokinin.

Authors:  B Rubin; S L Engel; A M Drungis; M Dzelzkalns; E O Grigas; M H Waugh; E Yiacas
Journal:  J Pharm Sci       Date:  1969-08       Impact factor: 3.534

3.  Synthetic secretin: comparison with natural secretin for potency and spectrum of physiological actions.

Authors:  M Vagne; G F Stening; F P Brooks; M I Grossman
Journal:  Gastroenterology       Date:  1968-08       Impact factor: 22.682

4.  Pylorus identification.

Authors:  W D Blackwood
Journal:  Gastroenterology       Date:  1969-08       Impact factor: 22.682

5.  Effects of fat, secretin, and cholecystokinin on histamine-stimulated gastric secretion.

Authors:  L R Johnson; M I Grossman
Journal:  Am J Physiol       Date:  1969-05

6.  Profile of pH, pressure, and potential difference at gastroduodenal junction in man.

Authors:  S Andersson; M I Grossman
Journal:  Gastroenterology       Date:  1965-10       Impact factor: 22.682

7.  Effect of secretin and cholecystokinin-pancreozymin extracts on gastric motility in man.

Authors:  L P Johnson; J C Brown; D F Magee
Journal:  Gut       Date:  1966-02       Impact factor: 23.059

8.  Effect of gastrin II on gastric emptying and secretion during a test meal.

Authors:  J N Hunt; N Ramsbottom
Journal:  Br Med J       Date:  1967-11-18

9.  Motor responses of the human alimentary tract to near-maximal infusions of pentagastrin.

Authors:  J J Misiewicz; D J Holdstock; S L Waller
Journal:  Gut       Date:  1967-10       Impact factor: 23.059

10.  The gastrointestinal stimulus to insulin release. I. Secretin.

Authors:  D J Chisholm; J D Young; L Lazarus
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

View more
  25 in total

1.  Organization of vagal afferents in pylorus: mechanoreceptors arrayed for high sensitivity and fine spatial resolution?

Authors:  Terry L Powley; Cherie N Hudson; Jennifer L McAdams; Elizabeth A Baronowsky; Felecia N Martin; Jacqueline K Mason; Robert J Phillips
Journal:  Auton Neurosci       Date:  2014-03-06       Impact factor: 3.145

2.  Effects of 13-nle-motilin on the electrical and mechanical activity of the isolated perfused canine stomach and duodenum.

Authors:  W E Green; H Ruppin; D L Wingate; W Domschke; D E Wünsch; L Demling; H D Ritchie
Journal:  Gut       Date:  1976-05       Impact factor: 23.059

3.  Hormonal control of gastrointestinal motility.

Authors:  R F Harvey
Journal:  Am J Dig Dis       Date:  1975-06

4.  Gastrin inhibition of the pyloric sphincter.

Authors:  R S Fisher; G Boden
Journal:  Am J Dig Dis       Date:  1976-06

5.  Evolution of nitric oxide regulation of gut function.

Authors:  Junko Yaguchi; Shunsuke Yaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-04       Impact factor: 11.205

6.  Effect of alterations in test meal composition on episodic transpyloric fluid movement in humans.

Authors:  P M King; A Pryde; R C Heading
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

7.  Strenuous exercise decreases motility and cross-sectional area of human gastric antrum. A study using ultrasound.

Authors:  B P Brown; M A Ketelaar; K Schulze-Delrieu; M M Abu-Yousef; C K Brown
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

Review 8.  Function-preserving gastrectomy for gastric cancer in Japan.

Authors:  Eiji Nomura; Kunio Okajima
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

9.  Tonic and phasic pyloric activity in response to CCK-octapeptide.

Authors:  Frank K Friedenberg; Joshua Desipio; Annapurna Korimilli; Matthew Bohning; Eva Sum; Henry P Parkman; Joel E Richter; Robert S Fisher
Journal:  Dig Dis Sci       Date:  2008-02-13       Impact factor: 3.199

10.  Mechanisms of insulin-induced relaxation of the canine proximal stomach after proximal gastric vagotomy.

Authors:  H Morimoto; K A Kelly
Journal:  J Gastrointest Surg       Date:  1997 Jul-Aug       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.